The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The American Board of Bada Bing

The American Board of Bada Bing

August 8, 2012 • By Bruce N. Cronstein, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
You got a really nice place on the web here, it would be a shame if somebody messed it up.

Recently, I received an email from a company called Avvo asking if I had seen my physician profile on their website. I was happy to see that I had received a physician rating, as a rheumatologist, of 8.9 (out of a possible score of 10, “excellent” in their description). When I looked at my profile, I found that I could look up the ratings of some other rheumatologists in the area to see how I compared. Although I was better than some (admittedly, not many), I found a number of colleagues who had perfect scores of 10, which, of course, stimulated my competitive juices. But then I remembered that I don’t see patients so, really, what difference did it make?

You Might Also Like
  • Rheumatology Board Recertification Exam Preparation Course
  • How to Complete Your Maintenance of Certification
  • American College of Rheumatology Wins Accreditation with Commendation by ACCME
Explore This Issue
August 2012
Also By This Author
  • Phoning It In

When I tried to figure out how I got such a good (but not perfect) rating, I found that I got 4.5/5 on experience, 5/5 for professional conduct, but only 1.5/5 for industry recognition (they obviously haven’t seen my disclosure statement). Looking back at the ratings for some of my colleagues (who also don’t see very many, if any, patients), the big difference was industry recognition. Clearly, making the web listing of various pharmaceutical companies, as mandated by the Sunshine Act, will now be considered a selling point for online doctor ratings.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

After a bit of reflection, I reconciled myself to a less than perfect rating but, just as I was getting over the shame and disappointment, I found out there was a new threat to my excellent rating. Somebody was offering me a “deal I could not refuse” in return for which they would not smear my name for online rating services like Avvo.

Offer We Can’t Refuse

The American Board of Internal Medicine (ABIM) has publicly announced their desire for all physicians to participate in the recertification program. The ABIM is developing an “education” program that I could—but did not have to—take that would be an equivalent of recertification for people of a certain age (like me) who took our boards before periodic recertifications were required. Although the ABIM could not suspend or rescind my boards, they would now note on their website that I was “cooperating” (or not) with their program. And the cost of recertification is not cheap.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Specialty and subspecialty recertification was an innovation instituted around two decades ago to insure that doctors would remain up to date in their fields. Many other countries (e.g., Canada, which has a general maintenance of certification program, but no specialty or subspecialty recertification requirements) have no requirements for recertification, and there is little evidence that care for patients with rheumatic diseases is inferior there. The requirement for recertification appeared at the same time as Continuing Medical Education (CME) credits, which are now required by most hospitals and some states for reaccreditation and licensure. The CME requirements spawned a very large industry (of which I am happily a part as codirector of a course), and the ABIM people must have thought they needed to expand their territory to compete.

What’s the Best Way to Get Results?

As members of a learned profession, we all strongly believe that continuing education is critical but, as we are now urged to be members of a data-driven profession as well, none of us have ever seen the evidence that CME courses or recertification have the intended outcome. Indeed, our best intentions have paved the way for the creation of a bureaucracy whose sole purpose is to protect us from the depredations of the pharmaceutical industry without any ability to ensure that the quality of the untainted information imparted at a CME course was high or that physicians will make the best use of it.

Pages: 1 2 | Single Page

Filed Under: Career Development, Certification, Education & Training, Professional Topics, Technology Tagged With: Certification, CME, Education, MOC, rheumatologist, TechnologyIssue: August 2012

You Might Also Like:
  • Rheumatology Board Recertification Exam Preparation Course
  • How to Complete Your Maintenance of Certification
  • American College of Rheumatology Wins Accreditation with Commendation by ACCME
  • Navigate Maintenance of Certification with the ACR

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.